- Home
- JAGX vs NIVF Comparison
JAGX vs NIVF Comparison
Compare JAGX & NIVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- NIVF
- Stock Information
- Founded
- JAGX 2013
- NIVF 2011
- Country
- JAGX United States
- NIVF Thailand
- Employees
- JAGX N/A
- NIVF N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- NIVF
- Sector
- JAGX Health Care
- NIVF
- Exchange
- JAGX Nasdaq
- NIVF NYSE
- Market Cap
- JAGX 9.6M
- NIVF 9.2M
- IPO Year
- JAGX N/A
- NIVF N/A
- Fundamental
- Price
- JAGX $0.94
- NIVF $0.66
- Analyst Decision
- JAGX
- NIVF
- Analyst Count
- JAGX 0
- NIVF 0
- Target Price
- JAGX N/A
- NIVF N/A
- AVG Volume (30 Days)
- JAGX 304.8K
- NIVF 811.1K
- Earning Date
- JAGX 11-13-2024
- NIVF 11-20-2024
- Dividend Yield
- JAGX N/A
- NIVF N/A
- EPS Growth
- JAGX N/A
- NIVF N/A
- EPS
- JAGX N/A
- NIVF 0.21
- Revenue
- JAGX $10,480,000.00
- NIVF $5,136,153.00
- Revenue This Year
- JAGX $32.33
- NIVF N/A
- Revenue Next Year
- JAGX $43.63
- NIVF N/A
- P/E Ratio
- JAGX N/A
- NIVF $3.03
- Revenue Growth
- JAGX N/A
- NIVF N/A
- 52 Week Low
- JAGX $0.90
- NIVF $0.55
- 52 Week High
- JAGX $30.84
- NIVF $17.24
- Technical
- Relative Strength Index (RSI)
- JAGX 40.43
- NIVF 44.49
- Support Level
- JAGX $0.95
- NIVF $0.60
- Resistance Level
- JAGX $1.20
- NIVF $0.78
- Average True Range (ATR)
- JAGX 0.09
- NIVF 0.08
- MACD
- JAGX -0.00
- NIVF -0.02
- Stochastic Oscillator
- JAGX 23.40
- NIVF 33.20
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.